Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor-Positive Breast Cancer: ASCO Guideline Clinical Insights
JCO Oncol Pract
.
2024 Aug 27:OP2400547.
doi: 10.1200/OP-24-00547.
Online ahead of print.
Authors
Igor Makhlin
1
,
Lesley Fallowfield
2
,
N Lynn Henry
3
,
Harold J Burstein
4
,
Mark R Somerfield
5
,
Angela DeMichele
6
Affiliations
1
Hospital of the University of Pennsylvania, Philadelphia, PA.
2
University of Sussex, Brighton, United Kingdom.
3
University of Michigan, Ann Arbor, MI.
4
Dana Farber Cancer Institute, Boston, MA.
5
American Society of Clinical Oncology, Alexandria, VA.
6
University of Pennsylvania, Philadelphia, PA.
PMID:
39190846
DOI:
10.1200/OP-24-00547
No abstract available